<p>Get up to date with the latest ESMO-EHA guideline for Peripheral T- and natural killer-cell lymphomas (<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/hem3.70128" target="_blank" rel="noopener noreferer">Peripheral T‐ and natural killer‐cell lymphomas: ESMO‐EHA Clinical Practice Guideline for diagnosis, treatment, and follow‐up - d&#39;Amore - 2025 - HemaSphere - Wiley Online Library</a>) Prof Francesco D&#39;Amore (Aarhus University, Denmark) and Prof Massimo Federico (University of Modena and Reggio Emilia, Italy). </p><p><br></p><p>In this episode, two key authors of the guidelines walk us through the recommendations for these rare, biologically diverse, and often aggressive- peripheral T cell and NK cell lymphomas. </p><p><br></p><p>Our guests explain the conscious effort of the guidelines panel to provide evidence based detailed recommendations for each subtype of PTCLs to improve diagnosis, treatment, and follow up. The emphasis is on moving away from “one size fits all” DLBCL style approach toward entity- adapted strategies. </p><p><br></p><p>Throughout the conversation, they stress the need to read the full guideline – including the supplementary material – and the importance of a multidisciplinary approach by experienced hematopathologists, ideally in expert or reference centres to give patients the best chance of appropriate, modern therapy.</p><p><br></p><p>GuestS: Prof Francesco D&#39;Amore and Prof Massimo Federico. </p><p>Professor Francesco D&#39;Amore is a Clinical Professor and Chair of the Department of Hematology at Aarhus University in Denmark </p><p>Professor Massimo Federico is a Senior Professor of Medical Oncology at the University of Modena and Reggio Emilia in Italy</p><p>Host: Isabel Olivera Martinez, PhD</p><p><br></p><p><strong>Learn More</strong></p><p><br></p><p>What did you think of this podcast? Share your opinions with us in this short feedback survey.</p><p><a href="https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1">⁠⁠⁠Provide Feedback⁠⁠⁠</a></p><p><br></p><p>Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.</p><p><a href="https://ehacampus.ehaweb.org/">⁠⁠⁠https://ehaedu.org/Campus⁠⁠⁠</a></p><p><br></p><p>Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.</p><p>Follow EHA on Instagram: <a href="https://www.instagram.com/EHA_Hematology/?utm_medium=podcast&utm_source=bcast&utm_campaign=eha-unplugged">⁠⁠⁠https://www.instagram.com/EHA_Hematology/⁠⁠⁠</a></p><p>Facebook: <a href="https://e-h-a.link/facebook?utm_medium=podcast&utm_source=bcast&utm_campaign=eha-unplugged">⁠⁠⁠https://e-h-a.link/facebook⁠⁠⁠</a></p><p>LinkedIn: <a href="https://www.linkedin.com/company/eha/?utm_medium=podcast&utm_source=bcast&utm_campaign=eha-unplugged">⁠⁠⁠https://www.linkedin.com/company/eha/⁠⁠⁠</a></p><p>Email us: [email protected]</p><p>Subscribe to receive the EHA Educational Updates via <a href="https://eha.news/subscribe?utm_medium=podcast&utm_source=bcast&utm_campaign=eha-unplugged">⁠⁠⁠https://eha.news/subscribe⁠⁠⁠</a> </p><p><br></p><p><br></p>